Other antibacterials, antivirals and antifungals
Antibacterials beyond the beta-lactams, grouped by target: vancomycin, aminoglycosides, macrolides, clindamycin, tetracyclines, fluoroquinolones, trimethoprim with sulfamethoxazole, metronidazole and rifampicin; then aciclovir, oseltamivir and boosted antivirals; and the azoles, amphotericin and echinocandins.
By the end of this page you should be able to
- Classify antibacterials by their target and give the spectrum and key toxicity of each class.
- Describe the pharmacology of vancomycin and gentamicin, including dosing and monitoring principles.
- Describe the important drug interactions of macrolides, fluoroquinolones, rifampicin, metronidazole and azoles.
- Explain the selectivity of aciclovir and the action of neuraminidase inhibitors.
- Compare the mechanisms and toxicities of the main antifungal classes.
Cell wall and membrane
- Vancomycin (glycopeptide) binds the D-alanyl-D-alanine end of peptidoglycan precursors, blocking their incorporation into the wall. Too large to cross the Gram-negative outer membrane, it is active against Gram-positives only: MRSA, coagulase-negative staphylococci, enterococci (unless vanA or vanB resistant), and orally for C. difficile (not absorbed). Slowly bactericidal; renally cleared; dosed to an AUC/MIC target, increasingly with Bayesian software, otherwise by trough levels. Toxicity: nephrotoxicity (more with piperacillin-tazobactam and other nephrotoxins) and the vancomycin infusion reaction (flushing and itch from direct histamine release when infused quickly; not an allergy, so slow the rate).
- Daptomycin inserts into Gram-positive membranes; inactivated by surfactant, so useless in pneumonia; causes myopathy (watch the CK).
Protein synthesis inhibitors
- Aminoglycosides (gentamicin, tobramycin, amikacin) bind the 30S subunit and cause misreading; bactericidal and concentration-dependent, with a post-antibiotic effect. Uptake into bacteria needs oxygen-dependent transport, so they do not work against anaerobes or in abscesses. Polar: not absorbed orally, volume of distribution about that of ECF, renally excreted unchanged. Toxicity: nephrotoxicity (saturable uptake into proximal tubular cells, which is why once-daily dosing is safer), ototoxicity, cochlear and vestibular, often permanent and more likely with a mitochondrial gene variant, and neuromuscular blockade (reduced presynaptic calcium entry; dangerous in myasthenia). Empirical courses are kept short, usually a few days, with levels if continued.
- Macrolides (azithromycin, clarithromycin, erythromycin, roxithromycin) bind 50S; bacteriostatic; atypical organisms, pertussis, some streptococci. QT prolongation. Erythromycin and clarithromycin strongly inhibit CYP3A4 (statins, DOACs, calcium channel blockers, some opioids); azithromycin barely does and has a very long tissue half-life. Erythromycin is a motilin agonist (prokinetic).
- Clindamycin binds 50S; good against streptococci, staphylococci and anaerobes; suppresses toxin production, so it is added in necrotising fasciitis and toxic shock. Strongly associated with C. difficile.
- Tetracyclines (doxycycline) block tRNA binding at 30S; bacteriostatic; atypicals, rickettsiae (including scrub typhus and Queensland tick typhus), Q fever, leptospirosis, some MRSA. Chelated by calcium, iron, magnesium and antacids; stain teeth and affect bone in young children and pregnancy; photosensitivity; oesophageal ulceration if swallowed lying down.
- Linezolid blocks the 50S initiation complex; MRSA and VRE; myelosuppression with prolonged use, and serotonin syndrome with serotonergic drugs (it is a weak MAO inhibitor).
DNA, folate and the rest
- Fluoroquinolones (ciprofloxacin, moxifloxacin) inhibit DNA gyrase and topoisomerase IV; bactericidal; excellent oral bioavailability (but chelated by cations). Ciprofloxacin covers Gram-negatives including Pseudomonas; moxifloxacin adds respiratory pathogens. Adverse: tendinopathy and rupture (older patients, steroids), QT prolongation, seizures and delirium, dysglycaemia, aortic aneurysm, C. difficile. Ciprofloxacin inhibits CYP1A2 (theophylline, clozapine). Use is restricted to preserve them.
- Trimethoprim with sulfamethoxazole blocks two steps of bacterial folate synthesis (sulfonamide: dihydropteroate synthase; trimethoprim: dihydrofolate reductase), a synergistic sequential block. Uses: UTI, Pneumocystis, some MRSA, Nocardia. Adverse: hyperkalaemia (trimethoprim blocks ENaC like amiloride), a rise in creatinine (blocked secretion), rash including SJS/TEN, marrow suppression, haemolysis in G6PD deficiency, and potentiation of warfarin (CYP2C9 inhibition).
- Metronidazole: a prodrug reduced only in anaerobes and some protozoa to radicals that damage DNA; anaerobes, C. difficile, Giardia, Trichomonas, amoebae. Metallic taste, nausea, neuropathy with long use, warfarin potentiation (CYP2C9), and advice to avoid alcohol.
- Rifampicin inhibits bacterial RNA polymerase; never used alone (resistance arises fast). A powerful inducer of CYP3A4 and other enzymes and transporters: it lowers levels of warfarin, DOACs, the oral contraceptive, antiretrovirals, azoles and many more. Turns urine, tears and contact lenses orange; hepatotoxic.
- Isoniazid (TB): hepatotoxicity, peripheral neuropathy (give pyridoxine); overdose causes refractory seizures treated with pyridoxine.
- Nitrofurantoin: concentrates in urine only; for cystitis, not pyelonephritis; less effective at low GFR.
Antivirals and antifungals
- Aciclovir (and its prodrug valaciclovir, with much better oral bioavailability) is a guanosine analogue. Viral thymidine kinase adds the first phosphate, so the drug is activated only in infected cells; host kinases complete the triphosphate, which inhibits viral DNA polymerase and terminates the chain. IV for HSV encephalitis. Adverse: crystal nephropathy (keep the patient well hydrated), neurotoxicity in renal failure. Resistance comes from thymidine kinase mutations.
- Oseltamivir inhibits influenza neuraminidase, which new virions need to leave the host cell. Greatest benefit when started early, but given to hospitalised and high-risk patients whenever they present.
- Nirmatrelvir with ritonavir (COVID-19): ritonavir is there only as a strong CYP3A4 inhibitor to boost nirmatrelvir, so it raises levels of many co-prescribed drugs.
- Azoles (fluconazole, voriconazole, posaconazole) inhibit fungal lanosterol 14-alpha-demethylase, a cytochrome P450 enzyme, blocking ergosterol synthesis. They also inhibit human CYPs: bleeding with warfarin, toxicity with statins and others; QT prolongation.
- Amphotericin B binds ergosterol and forms membrane pores; fungicidal, broad. Toxicity: nephrotoxicity, hypokalaemia and hypomagnesaemia, infusion reactions (fever, rigors). Lipid formulations are less toxic.
- Echinocandins (caspofungin, micafungin, anidulafungin) inhibit beta-1,3-glucan synthesis in the fungal wall, a target human cells lack; first line for candidaemia; few interactions.
Making the answer flow
- Start with the target (wall, membrane, 30S, 50S, nucleic acid, folate), then name the drugs on it. It turns a list into a structure.
- For gentamicin and vancomycin, cover the PK/PD index and how that sets the dose, then the monitoring.
- For interactions, say whether the drug induces or inhibits, which enzyme, and give one dangerous pair.
Where marks are lost
- Calling the vancomycin infusion reaction an allergy.
- Expecting gentamicin to treat an abscess or anaerobic infection.
- Saying rifampicin inhibits CYP enzymes. It induces them; azoles and erythromycin inhibit.
- Saying a rising creatinine on trimethoprim always means renal injury.
- Putting aciclovir activation down to host kinases alone; selectivity comes from viral thymidine kinase.
Where this meets intensive care
- Aminoglycosides are concentration-dependent with a post-antibiotic effect, so a single large daily dose maximises the peak and allows trough levels to fall, reducing toxicity.
- Vancomycin is renally cleared and its target is an area under the curve to MIC ratio; levels guide dosing in changing renal function and on dialysis.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
Describe the pharmacology of gentamicin.
Show answer
- Aminoglycoside; binds 30S, causes misreading and membrane damage; bactericidal, concentration-dependent, post-antibiotic effect.
- Aerobic Gram-negatives including Pseudomonas; synergy with beta-lactams against enterococci and streptococci; no anaerobic activity.
- IV; Vd about ECF; not metabolised; renal excretion; half-life lengthens with low GFR.
- Toxicity: nephrotoxicity, oto and vestibular toxicity, neuromuscular blockade; once-daily dosing with level monitoring if continued.
- 2.
Why is gentamicin given once daily?
Show answer
- Killing depends on peak/MIC, so a high peak improves efficacy.
- Long post-antibiotic effect covers the low trough period.
- Uptake into renal tubular and inner ear cells is saturable, so one high dose causes less accumulation than several smaller doses.
- Adaptive resistance is reduced by drug-free intervals.
- 3.
Describe the pharmacology of vancomycin.
Show answer
- Glycopeptide; binds D-Ala-D-Ala of peptidoglycan precursors; slowly bactericidal; Gram-positives only.
- IV for systemic infection (poor oral absorption, used orally for C. difficile); renal excretion.
- AUC/MIC-guided dosing; loading dose by weight.
- Adverse: nephrotoxicity, infusion reaction from histamine release, rarely ototoxicity and neutropenia.
- Resistance: altered precursor (D-Ala-D-Lac) in VRE.
- 4.
A patient on warfarin is started on an antibiotic and their INR rises. Which antibiotics are likely and how?
Show answer
- Trimethoprim with sulfamethoxazole, metronidazole and fluconazole inhibit CYP2C9, which metabolises the more potent S-warfarin.
- Macrolides and other azoles inhibit CYP3A4 (R-warfarin, smaller effect).
- Any broad-spectrum antibiotic can reduce vitamin K from gut flora; infection itself raises INR.
- Rifampicin does the opposite: induction drops the INR.
- 5.
Why is clindamycin added in necrotising fasciitis?
Show answer
- Inhibits protein synthesis at 50S, so it reduces production of streptococcal and staphylococcal exotoxins (superantigens).
- Its effect does not depend on bacterial growth rate, unlike beta-lactams, which work less well when a large bacterial load is in stationary phase.
- Used together with a beta-lactam, plus urgent surgical debridement.
- 6.
How does aciclovir achieve selective toxicity?
Show answer
- Nucleoside analogue phosphorylated by viral thymidine kinase, which host kinases do poorly.
- Host kinases convert to triphosphate, which competes with dGTP for viral DNA polymerase and terminates the chain.
- Viral polymerase has higher affinity than host polymerase.
- Resistance from thymidine kinase or polymerase mutations.
- 7.
What are the adverse effects of fluoroquinolones?
Show answer
- Tendinopathy and tendon rupture, especially Achilles, older patients and with steroids.
- QT prolongation; CNS effects (seizures, delirium, insomnia); dysglycaemia; peripheral neuropathy.
- Aortic aneurysm and dissection risk; C. difficile; photosensitivity.
- Interactions: chelation by cations; ciprofloxacin inhibits CYP1A2.
- 8.
Compare azoles, amphotericin and echinocandins.
Show answer
- Azoles: inhibit ergosterol synthesis (fungal CYP51); oral and IV; many human CYP interactions; hepatotoxicity, QT.
- Amphotericin: binds ergosterol, forms pores; fungicidal; nephrotoxicity, hypokalaemia, hypomagnesaemia, infusion reactions.
- Echinocandins: inhibit beta-1,3-glucan synthase in the cell wall; IV only; well tolerated; first line for candidaemia.
- 9.
Why must rifampicin never be used alone, and what are its main interactions?
Show answer
- Single-step mutations in RNA polymerase (rpoB) give high-level resistance quickly.
- Strong inducer of CYP3A4, CYP2C9 and P-glycoprotein through the pregnane X receptor; full effect over 1 to 2 weeks and lasts weeks after stopping.
- Lowers warfarin, DOACs, oral contraceptives, antiretrovirals, azoles, steroids, methadone.
Practise this week
- First Part MCQs: sepsis and microbiology
- First Part MCQs: pharmacology
- First Part SAQs, marked part by part
- First Part cross-table vivas
- Viva Examiner: practise answering aloud
Week 22 in the other subjects
- Physiology: Glucose, calcium and temperature regulation
- Measurement: Humidity, heat and temperature measurement
Not affiliated with the CICM. Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.